» Articles » PMID: 8206907

Structural Requirements for Interleukin-8 Function Identified by Design of Analogs and CXC Chemokine Hybrids

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1994 Jun 10
PMID 8206907
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Structure-activity relationships of human interleukin-8 (IL-8) were probed using chemically synthesized analogs with single or double amino acid substitutions, as well as hybrids derived by substituting IL-8 regions into IP10, a related protein that lacks IL-8 activity. The analogs were tested for functional activity by measuring induction of elastase release from human neutrophils and competition for binding of radiolabeled IL-8. The hybrid studies indicated that Gly31 and Pro32, as well as the NH2-terminal region from IL-8 are required to convert IP10 into a fully functional protein, suggesting that these elements are critical for IL-8 activity. Both disulfide bridges, linking residue 7 to 34 and residue 9 to 50, were critical for function, as shown by substituting the cysteine pairs with alpha-aminobutyric acid. Single conservative substitutions were generally accepted into the 10-22 region of IL-8, which contrasts with the ELR motif (residues 4-6), previously shown to be essential for activity. The importance of residues within the 10-15 region and the 17-22 region was demonstrated with hybrids. In addition, some of the 4-22 residues have structural roles that may be important; for example, Tyr13, Phe17, and Phe21 are involved in aromatic interactions in the IL-8 structure, and are also moderately sensitive to modification. Except for Cys50, the results argue against a role for the 36-72 region, including the COOH-terminal alpha-helix, in receptor binding. We conclude that the disulfide bridges and 30-35 turn provide a structural scaffold for the NH2-terminal region which includes the primary receptor-binding site (the ELR motif) and secondary binding and conformational determinants between residues 10 and 22.

Citing Articles

Cystathionine γ-lyase-derived HS negatively regulates thymic egress via allosteric inhibition of sphingosine-1-phosphate lyase.

Hu Y, Liu Z, Zhang T, Ma Y, He L, Zhang J Acta Pharmacol Sin. 2024; 45(11):2366-2379.

PMID: 38914678 PMC: 11489676. DOI: 10.1038/s41401-024-01322-8.


NLRP6 controls pulmonary inflammation from cigarette smoke in a gut microbiota-dependent manner.

Nascimento M, Huot-Marchand S, Fanny M, Straube M, Le Bert M, Savigny F Front Immunol. 2023; 14:1224383.

PMID: 38146368 PMC: 10749332. DOI: 10.3389/fimmu.2023.1224383.


Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19.

Julian D, Kazakoff M, Patel A, Jaynes J, Willis M, Yates C Curr Pathobiol Rep. 2021; 9(4):93-105.

PMID: 34900402 PMC: 8651461. DOI: 10.1007/s40139-021-00226-0.


A highly efficient method for the production and purification of recombinant human CXCL8.

McKenna S, Giblin S, Bunn R, Xu Y, Matthews S, Pease J PLoS One. 2021; 16(10):e0258270.

PMID: 34653205 PMC: 8519433. DOI: 10.1371/journal.pone.0258270.


The Role of Streptococcal Cell-Envelope Proteases in Bacterial Evasion of the Innate Immune System.

McKenna S, Huse K, Giblin S, Pearson M, Majid Al Shibar M, Sriskandan S J Innate Immun. 2021; 14(2):69-88.

PMID: 34649250 PMC: 9082167. DOI: 10.1159/000516956.